30 completed, 2 terminated, 2 unknown. 22 Phase 1, 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 22 | Completed 21, Unknown 1 |
| Phase 3 | 7 | Completed 5, Terminated 2 |
| Phase 2 | 3 | Completed 3 |
Follow lasmiditan: new trials by email Literature Review of lasmiditan trials Research Report on lasmiditan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) Patients with migraine treated with triptans, Lasmiditan or Gepants - Migraine, Migraine Disorders | Unknown | Hospital Clínico Universitario de Valladolid | 1500 | 2023-12-04 | 2024-02-21 | |
| Ditan Acute tReatments: Effectiveness and Tolerability (DART) Lasmiditan - Migraine, Migraine With Aura | Completed | University of Florence | 100 | 2023-06-15 | 2026-01-21 | |
| A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants Lasmiditan - Healthy | Phase 1 | Completed | Eli Lilly and Company | 47 | 2021-05-14 | 2023-03-23 |
| A Study of Lasmiditan in Healthy Volunteers Lasmiditan, Dabigatran Etexilate, Rosuvastatin - Healthy | Phase 1 | Completed | Eli Lilly and Company | 97 | 2021-02-15 | 2024-02-01 |
| A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine Lasmiditan - Migraine | Phase 3 | Terminated | Eli Lilly and Company | 558 | 2020-06-30 | 2026-06-25 |
| A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine Lasmiditan, Placebo - Migraine | Phase 3 | Terminated | Eli Lilly and Company | 847 | 2020-06-15 | 2026-09-02 |
| Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean Lasmiditan 50mg, Lasmiditan 100mg, Placebo - Acute Migraine | Phase 3 | Completed | IlDong Pharmaceutical Co Ltd | 294 | 2020-03-24 | 2021-04-01 |
| A Study of Lasmiditan in Healthy Chinese Participants Lasmiditan, Placebo - Healthy | Phase 1 | Completed | Eli Lilly and Company | 36 | 2019-11-13 | 2021-07-01 |
| Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers COL-144 50mg, COL-144 100mg, COL-144 200mg - Healthy | Phase 1 | Unknown | IlDong Pharmaceutical Co Ltd | 64 | 2019-08-01 | 2019-05-06 |
| A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine Lasmiditan - Migraine | Phase 1 | Completed | Eli Lilly and Company | 18 | 2019-07-22 | 2020-09-01 |
| A Study of Lasmiditan (LY573144) Over Four Migraine Attacks Lasmiditan, Placebo - Migraine | Phase 3 | Completed | Eli Lilly and Company | 1633 | 2019-06-24 | 2022-07-29 |
| A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine Lasmiditan, Placebo - Migraine | Phase 2 | Completed | Eli Lilly and Company | 846 | 2019-05-31 | 2021-06-11 |
| A Study of Lasmiditan in Healthy Japanese and Caucasian Participants Lasmiditan, Placebo - Healthy | Phase 1 | Completed | Eli Lilly and Company | 27 | 2018-06-27 | 2019-11-29 |
| A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants Lasmiditan, Placebo, Diphenhydramine - Healthy | Phase 1 | Completed | Eli Lilly and Company | 68 | 2018-03-26 | 2020-01-13 |
| A Study of Lasmiditan in Healthy Elderly Participants Lasmiditan, Placebo - Healthy | Phase 1 | Completed | Eli Lilly and Company | 36 | 2018-01-25 | 2019-12-02 |
| A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants Lasmiditan, Sumatriptan, Placebo for Lasmiditan - Healthy | Phase 1 | Completed | Eli Lilly and Company | 40 | 2017-10-17 | 2019-11-27 |
| A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate Lasmiditan, Placebo, Topiramate - Healthy | Phase 1 | Completed | Eli Lilly and Company | 30 | 2017-10-16 | 2019-11-27 |
| A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users Lasmiditan, Alprazolam, Placebo - Recreational Drug Use, Prescription Drug Abuse (Not Dependent) | Phase 1 | Completed | Eli Lilly and Company | 96 | 2017-09-15 | 2020-01-10 |
| A Study of Lasmiditan and Propranolol in Healthy Participants Lasmiditan, Propranolol - Healthy | Phase 1 | Completed | Eli Lilly and Company | 44 | 2017-08-31 | 2019-12-16 |
| A Study of Lasmiditan in Participants With Migraine Lasmiditan - Migraine Disorders | Phase 1 | Completed | Eli Lilly and Company | 16 | 2017-08-16 | 2019-12-02 |
Showing 20 of 34. Sign in to see all of them.
Migraine Disorders (15) · Headache (2) · Migraine with Aura (2) · Headache Disorders (1) · Headache Disorders, Secondary (1) · Migraine without Aura (1) · Pain (1) · Recreational Drug Use (1) · Substance-Related Disorders (1)
Eli Lilly and Company (30) · IlDong Pharmaceutical Co Ltd (2) · Hospital Clínico Universitario de Valladolid (1) · University of Florence (1)
United States (21) · Germany (7) · Canada (5) · Spain (5) · Belgium (4) · France (4) · Italy (4) · Japan (4) · Netherlands (4) · United Kingdom (4) · India (3) · Mexico (3) · Puerto Rico (3) · Russia (3) · China (2)
PMID 35471625, PMID 35779194, PMID 37965170, PMID 32447545, PMID 33730977, PMID 33784930, PMID 34366152, PMID 34644189, PMID 31152441, PMID 31166697, PMID 31266353, PMID 31340760, PMID 31409292, PMID 31464581, PMID 31529622, PMID 31744319, PMID 32783644, PMID 34454420, PMID 35350937, PMID 35979677, PMID 36125279, PMID 20855362, PMID 22459549, PMID 30446595, PMID 30496104, PMID 31433669, PMID 32093628, PMID 33541117, PMID 33565026, PMID 34742230, PMID 35713760, PMID 35748397, PMID 36114949, PMID 36136232, PMID 36950929, PMID 37255987, PMID 38528476, PMID 41446321
2015 (2), 2019 (2), 2023 (2), 2008 (1), 2018 (1)